Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
Por um escritor misterioso
Descrição
Improving the Diagnosis of Neuromyelitis Optica Spectrum Disorder - Neurology Advisor
A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course. - Abstract - Europe PMC
Electrophysiologic and MRI Outcomes in Multiple Sclerosis (MS) and
Frontiers Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome
Frontiers Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Frontiers Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue - ScienceDirect
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
Retinal architecture, vasculature, and surrogate markers of disease
The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-β therapy in the 3-year follow-up: a preliminary report
IJMS, Free Full-Text
Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis
PDF) MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)